Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Late cornified envelope protein 4A (LCE4A) is a protein primarily expressed in the skin, classified among the late cornified envelope (LCE) family of proteins involved in the terminal differentiation of keratinocytes and the formation of the skin barrier. It acts as a precursor of the cornified envelope, a structure assembled in the late steps of epidermal differentiation, replacing the plasma membrane of granular keratinocytes during cornification[1][3][5][7]. LCE4A enables identical protein binding activity and is predicted to be involved in keratinization, contributing to the mechanical strength and protective function of the epidermis[1][4][7]. Defects or variants in the LCE4A gene have been associated with skin barrier disorders such as candidal paronychia and syndromic ectodermal dysplasia, but there is no evidence that LCE4A itself is a direct drug target or that it interacts with known pharmacological agents[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Late cornified envelope protein 4A (LCE4A).